Clinical Trial: Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901894) titled 'Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea' on Oct. 14.

Brief Summary: This study seeks to evaluate the efficacy and safety of the fixed dose combination of dexketoprofen/butylscopolamine compared to dexketoprofen for the treatment of primary dysmenorrhea in 130 mexican women.

Study Start Date: July 02, 2025

Study Type: INTERVENTIONAL

Condition: Primary Dysmenorrhea

Intervention: DRUG: Dexketoprofen / Butylscopolamine in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.)

Formula: 25 mg / 10 mg Pharmaceutical Form: Tablet D...